Company Assembles Physicians and Researchers Specializing in Ear Diseases to Guide Novel Treatments to Clinic
SAN DIEGO, March 30 /PRNewswire/ -- Otonomy Inc. today introduced its scientific advisory board comprised of physicians and research scientists specializing in diseases and disorders of the ear.
The advisory board includes three of the company's founders: Rick Friedman, M.D., Ph.D.; Jeffrey Harris, M.D., Ph.D.; and Allen Ryan, Ph.D. Joining the founders on the advisory board are Stephan Heller, Ph.D.; Charles Liberman, Ph.D.; Christopher Post, M.D., Ph.D.; and Alec Salt, Ph.D.
"We are honored that this prestigious group of internationally recognized experts in the field of otology will guide the clinical development of Otonomy's proprietary drug products," said Jay Lichter, Ph.D., Otonomy's president and CEO and one of the company's founders. "The scientific guidance of this panel will be integral to the development of new therapies for diseases that are currently untreatable, such as Meniere's disease and sensorineural, age-related and noise-induced hearing loss."
About the Scientific Advisory Board Members:
Rick Friedman, M.D., Ph.D.
Dr. Friedman is the research section chief of hereditary ear disorders in the department of Cell and Molecular Biology at the House Ear Institute in Los Angeles. Dr. Friedman is currently Chief of Skull Base Surgery at Cedars Sinai Medical Center and is actively caring for patients with Skull Base Tumors at Cedars Sinai and St. Vincent Medical Center. His area of expertise is the study of hereditary deafness. Dr. Friedman served as a resident in the division of Otolaryngology at the UCSD Medical Center while earning his Ph.D. from the
|SOURCE Otonomy Inc.|
Copyright©2009 PR Newswire.
All rights reserved